Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
4.110
+0.160 (4.05%)
At close: Feb 21, 2025, 4:00 PM
4.150
+0.040 (0.97%)
After-hours: Feb 21, 2025, 5:52 PM EST
MRVI Revenue by Segment
History
| Date | Nucleic Acid Production | Biologics Safety Testing | Protein Detection |
|---|---|---|---|
| Sep 30, 2024 | 213.27M | 63.65M | - |
| Jun 30, 2024 | 214.55M | 64.03M | - |
| Mar 31, 2024 | 209.33M | 64.77M | - |
| Dec 31, 2023 | 224.77M | 64.18M | - |
| Sep 30, 2023 | 355.23M | 64.29M | - |
| Jun 30, 2023 | 478.89M | 65.03M | - |
| Mar 31, 2023 | 650.88M | 66.86M | - |
| Dec 31, 2022 | 813.08M | 69.93M | - |
| Sep 30, 2022 | 836.30M | 70.44M | - |
| Jun 30, 2022 | 844.32M | 70.69M | - |
| Mar 31, 2022 | 811.80M | 71.41M | - |
| Dec 31, 2021 | 712.32M | 68.42M | - |
| Sep 30, 2021 | 577.56M | 66.61M | 25.44M |
| Jun 30, 2021 | 462.31M | 64.10M | 26.24M |
| Mar 31, 2021 | 300.00M | 58.25M | 23.31M |
| Dec 31, 2020 | 206.32M | 54.90M | 22.88M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.